In April 2005, DNDi announced the development of an artesunate and amodiaquine co-formulation in a single tablet, which should become the indispensable treatment for malaria.
In April 2005, DNDi announced the development of an artesunate and amodiaquine co-formulation in a single tablet, which should become the indispensable treatment for malaria.